P220023/S011: Paradise Ultrasound Renal Denervation System (Paradise System)
FDA’s recorded scope: Approval of revision to the protocol for the Post-Approval Study (PAS) referenced above.
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 3 FDA records to the applicant name Recor Medical, Inc.. 1 entry is a PMA supplement. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Sep 11, 2025 to Aug 13, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QYI appears in 3 of the 3 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P220023, with 3 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 1049 Elwell Ct., Palo Alto, CA, 94303. Recorded on P220023/S011, decision dated Aug 13, 2026.
FDA’s recorded scope: Approval of revision to the protocol for the Post-Approval Study (PAS) referenced above.
FDA’s recorded scope: approval for changes to the manufacturing process of the ultrasound transducer
FDA’s recorded scope: automated processes for determining transducer measurements and programming parameters into the catheter EEPROM
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
MedtechLedger links 2 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 2 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Recor Medical, Inc. | Class II | Apr 8, 2026 | FDA | |
| Recor Medical, Inc. | Class II | Apr 8, 2026 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Source updated Nov 11, 2026. Retrieved Nov 21, 2026.
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.